When economic interests are at stake, it is natural for an industry to push back. Mounting scientific evidence and increased consumer awareness are both needed, generally, to push economic interests to a secondary position. In this particular case, however, consumer awareness appears to have moved well ahead with only a little scientific research. The potential for consumers to view the industry’s attempt to rebrand as devious has caused sufficient concerns with in FDA. At least a few in FDA appear to be concerned of a harm to its credibility by rubber stamping the request from the industry
This incidence is another sign of impending changes in global consumerism that has fuelled the economy of developed countries in past few decades. It is strange that a shift is starting during times of a severe economic downturn.